BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12

• Press Releases

  Microbix Updates Investor Presentation on its Website

  January 9, 2026

   · 

  5 min read
• Press Releases

  Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases

  January 9, 2026

   · 

  6 min read
• Press Releases

  Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)

  January 9, 2026

   · 

  4 min read
• Press Releases

  Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis

  January 9, 2026

   · 

  5 min read
• Press Releases

  GC Therapeutics Appoints Kate Haviland as Board Chair and Provides Corporate Update

  January 9, 2026

   · 

  6 min read
• Press Releases

  Clarametyx Biosciences Announces Positive Topline Data From Phase 2a Study Evaluating CMTX-101 in Cystic Fibrosis

  January 9, 2026

   · 

  4 min read
• Press Releases

  Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign

  January 9, 2026

   · 

  5 min read
• Press Releases

  Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors

  January 9, 2026

   · 

  3 min read
• Press Releases

  Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026

  January 9, 2026

   · 

  1 min read
• Press Releases

  Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies

  January 9, 2026

   · 

  14 min read